Who
John Hohneker
Director
Company insider
Files Form 4 as: Director, Curis; Director, ArriVent BioPharma; Director, Carisma Therapeutics; Director, Evelo Biosciences; Director, Aravive; Director, Humanigen; Director, Dimension Therapeutics.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 18 Jan 2017
- Last trade
- 7 Jul 2026
- Last filed
- 9 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $36K6,800 at $5.29 | filing |
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $36K6,800 at $5.29 | filing |
| 18 Jun 2026filed 22 Jun 2026 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,562 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,562 at $0.00 | filing |
| 18 Jun 2025filed 20 Jun 2025 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,502 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $45K14,400 at $3.13 | filing |
| 28 Jan 2025filed 30 Jan 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $5,0081,600 at $3.13 | filing |
| 26 Jun 2024filed 27 Jun 2024 | Carisma Therapeuticsoption or derivative | SEC FORM 4 Code A | —19,350 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $49K4,250 at $11.62 | filing |
| 16 May 2024filed 20 May 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,550 at $0.00 | filing |
| 1 Apr 2024filed 1 Apr 2024 | Carisma Therapeuticsoption or derivative | SEC FORM 4 Code A | —38,700 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | Evelo Biosciencesoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Jan 2023filed 24 Jan 2023 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 23 Sep 2022filed 26 Sep 2022 | Araviveoption or derivative | SEC FORM 4 Code A | —97,063 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | Humanigenoption or derivative | SEC FORM 4 Code A | —63,195 at $0.00 | filing |
| 9 Jun 2022filed 13 Jun 2022 | Evelo Biosciencesoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 31 Jan 2022filed 31 Jan 2022 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 31 Dec 2021filed 4 Jan 2022 | Humanigenoption or derivative | SEC FORM 4 Code A | $10K3,538 at $2.84 | filing |
| 2 Dec 2021filed 6 Dec 2021 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 Oct 2021filed 20 Oct 2021 | Humanigenoption or derivative | SEC FORM 4 Code A | —42,866 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.